Clinical Trial Update: Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia

View source ↗

Summary

A completed clinical trial evaluating intravenous pentamidine for Pneumocystis jirovecii pneumonia in patients with hematologic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• Pentamidine (pentamidine)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Hematologic Malignancy | Status: COMPLETED